ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

462
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
bearishPosco Future M
22 May 2023 07:03

Korea: What Are Foreign Investors Buying & Selling?

Foreign investors have been buying stock in Korea and hold 32% of the KOSPI market cap and 8.5% of the KOSDAQ market cap. There is a big dispersion...

Logo
449 Views
Share
bullishSK Pharmteco
17 May 2023 17:11

SK Pharmteco Pre-IPO Funding & Impact on SK Inc

SK Pharmteco is seeking valuation of about 5 trillion won which is much higher than its book value of 1.65 trillion won. SK Pharmteco (100% owned...

Logo
331 Views
Share
bullishCelltrion Inc
15 May 2023 17:37

Celltrion Inc (068270 KS): Turning Bullish As Biosimilar Revenue Rebounds & US Launches Imminent

Celltrion reported record-high biosimilar quarterly revenue of KRW400B+ in Q1, leading to double-digit revenue and operating profit growth. The...

Logo
249 Views
Share
03 Apr 2023 05:47

Short Interest Movements (Q1 2023): HK, Korea, Taiwan, Australia

The Insight looks at movements in short interest across HK, Korea, Taiwan and Australia stocks over Q1 and highlights large increases/decreases in...

Logo
434 Views
Share
06 Mar 2023 14:53

Long Short Setup Candidate: Posco Holdings & Celltrion with TIGER Top 10 Rebalancing

TIGER Top 10 ETF's upcoming rebalancing, scheduled for June 9, presents a feasible long short trade setup on Posco Holdings and Celltrion.

Logo
394 Views
Share
x